Why Is TransCode Therapeutics (RNAZ) Stock Down 62% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
TransCode Therapeutics stock is down on Tuesday after the biopharmaceutical company priced a public offering of RNAZ shares.
The post Why Is TransCode Therapeutics (RNAZ) Stock Down 62% Today? appeared first on InvestorPlace.
More From InvestorPlace